Comment
doi: 10.1136/bmj.317.7151.149a.
Levonorgestrel intrauterine device can be left in place for five years
- PMID: 9657811
- PMCID: PMC1113513
- DOI: 10.1136/bmj.317.7151.149a
Item in Clipboard
Comment
Levonorgestrel intrauterine device can be left in place for five years
BMJ.
.
No abstract available
Comment on
-
Data support extended use of levonorgestrel intrauterine systems.BMJ. 1998 May 30;316(7145):1671. doi: 10.1136/bmj.316.7145.1671. BMJ. 1998. PMID: 9603759 Free PMC article. No abstract available.
Similar articles
-
Algorithm for nonvisible strings of levonorgestrel intrauterine system.J Minim Invasive Gynecol. 2010 Nov-Dec;17(6):805-6. doi: 10.1016/j.jmig.2010.07.014. J Minim Invasive Gynecol. 2010. PMID: 20955995
-
The levonorgestrel-releasing intrauterine system for menorrhagia.Br J Hosp Med (Lond). 2006 Jan;67(1):46. Br J Hosp Med (Lond). 2006. PMID: 16447415 No abstract available.
-
[Recommendations for the levonorgestrel intrauterine system (LNG-IUS). 2006].Ceska Gynekol. 2007 Apr;72(2):149-50. Ceska Gynekol. 2007. PMID: 17639740 Czech. No abstract available.
-
Gynaecological aspects of the levonorgestrel-releasing intrauterine system.Br J Obstet Gynaecol. 1997 Mar;104(3):285-9. doi: 10.1111/j.1471-0528.1997.tb11455.x. Br J Obstet Gynaecol. 1997. PMID: 9091003 Review. No abstract available.
-
[Levonorgestrel capsules: a big leap forward in intrauterine contraception].Ned Tijdschr Geneeskd. 1996 Jun 8;140(23):1212-4. Ned Tijdschr Geneeskd. 1996. PMID: 8700269 Review. Dutch. No abstract available.
Cited by
-
Recent advances in managing and understanding menstrual disorders.F1000Prime Rep. 2015 Mar 3;7:33. doi: 10.12703/P7-33. eCollection 2015. F1000Prime Rep. 2015. PMID: 25926984 Free PMC article. Review.
-
Medical treatment of uterine leiomyoma.Reprod Sci. 2012 Apr;19(4):339-53. doi: 10.1177/1933719111432867. Epub 2012 Feb 28. Reprod Sci. 2012. PMID: 22378865 Free PMC article. Review.
References
-
- Sivin I, El Mahgoub S, McCarthy T, Mishell DR, Jr, Shoupe D, Alvarez F, et al. Long term contraception with the levonorgestrel 20 mcg/day (LNg20) and the Copper T 380 Ag intrauterine devices: a five year randomised study. Contraception. 1990;42:361–378. - PubMed
-
- Sivin I, Stern J, Coutinho E, Mattos C, El Mahgoub S, Diaz S, et al. Prolonged intrauterine contraception: a seven year randomised study of the levonorgestrel 20 mcg/day (LNg20) and the Copper T 380 Ag IUDs. Contraception. 1991;44:473–480. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
